Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.

NCT00938665 is registered in ClinicalTrials.gov with Neuronetrix, Inc. as lead sponsor.

NCT NCT00938665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00938665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Lead sponsor
Neuronetrix, Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2010
Completion date
February 28, 2014
Enrollment
204 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment, dementia, frontotemporal dementia, memory disorders